Clinical Trials Directory

Trials / Completed

CompletedNCT01895088

A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A

A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
271 (actual)
Sponsor
AcuFocus, Inc. · Industry
Sex
All
Age
45 Years – 60 Years
Healthy volunteers
Accepted

Summary

This is a 2 year follow up study to monitor the long term safety of the ACI 7000PDT in subjects who are still implanted with the ACI and have successfully completed the ACU-P08-020/020A studies.

Detailed description

This is a two year follow up study designed to monitor and obtain long-term safety data of the ACI 7000PDT in subjects who participated and successfully completed the ACU-P08-020/020A studies. Subjects must be able to provide voluntary informed consent, and must sign and be given a copy of the written Informed Consent form prior to participating. This continuation study follows subjects still implanted with the ACI and includes two visits, at 12-month intervals, after subjects have been exited (at Month 36) from the ACU-P08-020/020A studies. The first visit is at Month 48 following implantation followed by a final Month 60 visit. The study parameters being measured at these two visits include: * Specular microscopy * Slit lamp and fundus examination (ocular health) * Corrected and uncorrected visual acuity * Manifest mid-point refraction * Corneal topography * Dry eye assessment * Mesopic and Photopic contrast sensitivity * Adverse events and complications All sites participating in the ACU-P08-020/020A studies were invited to participate in the continuation study.

Conditions

Interventions

TypeNameDescription
DEVICEAcuFocus Corneal Inlay ACI 7000 PDTInlay implanted in cornea for improvement of near vision

Timeline

Start date
2011-05-01
Primary completion
2015-04-01
Completion
2015-08-01
First posted
2013-07-10
Last updated
2017-08-01
Results posted
2017-06-28

Locations

13 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01895088. Inclusion in this directory is not an endorsement.